Dual roles of ATM in the cellular response to radiation and in cell growth control

Genes and Development

Volumn 10, Issue 19, 1996, Pages 2401-2410

  Xu, Yang ^a   Baltimore, David ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

cell cycle arrest; cellular proliferation; DNA repair; p21; p53

Indexed keywords

PROTEIN P21; PROTEIN P53;

ARTICLE; ATAXIA TELANGIECTASIA; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; GAMMA IRRADIATION; GENE EXPRESSION REGULATION; GENETIC SUSCEPTIBILITY; GROWTH REGULATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMOCYTE; TUMOR SUPPRESSOR GENE;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0029821651     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.19.2401     Document Type: Article

References (44)

1. Barlow, C., S. Hirotsune, R. Paylor, M. Liyanage, M. Eckhaus, F. Collins, Y. Shiloh, J.N. Crawley, T. Ried, D. Tagle, and A. Wynshaw-Boris. 1996. Atm-deficient mice, a paradigm of ataxia-telangiectasia. Cell 86: 159-171.
2. Beg, A.A., W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa β. Nature 376: 167-170.
3. Blunt, T., N.J. Finnie, G.E. Taccioli, G.C. Smith, J. Demengeot, T.M. Gottlieb, R. Mizuta, A.J. Varghese, F.W. Alt, P.A. Jeggo, and S.P. Jackson. 1995. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 80: 813-823.
4. Brown, E.J., P.A. Beal, C.T. Keith, J. Chen, T.B. Shin, and S.L. Schreiber. 1995. Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature 377: 441-446.
5. Brugarolas, J., C. Chandrasekaran, J.I. Gordon, D. Beach, T. Jacks, and G.J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557.
6. Canman, C.E., A.C. Wolff, C.Y. Chen, A.J. Fornace, Jr., and M.B. Kastan. 1994. The p53-dependent G1 cell cycle checkpoint pathways and ataxia-telangiectasia. Cancer Res. 54: 5054-5058.
7. Carpenter, C.L., K.R. Auger, B.C. Duckworth, W.M. Hou, B. Schaffhausen, and L.C. Cantley. 1993. A tightly associated serine/threonine kinase regulates phosphoinositide 3-kinase activity. Mol. Cell. Biol. 13: 1657-1665.
8. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper, and A.H. Wylie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852.
9. Deng, C., P. Zhang, J.W. Harper, S.J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
10. Dhand, R., I. Hiles, G. Panayotou, S. Roche, M.J. Fry, I. Gout, N.F. Totty, O. Truong, P. Vicendo, K. Yonezawa, M. Kasuga, S.A. Courtneidge, and M.D. Waterfield. 1994. PI 3-kinase is a dual specificity enzyme: Autoregulation by an intrinsic protein-serine kinase activity. EMBO J. 13: 522-533.
11. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.E. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
12. Greenwell, P.W., S.L. Kronmal, S.E. Porter, J. Gassenhuber, B. Obermaier, and T.D. Petes. 1995. TEL1, a gene involved in controlling telomere length in S. cerevisiae, is homologous to the human ataxia telangiectasia gene. Cell 82: 823-829.
13. Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
14. Hari, K.L., A. Santerre, J.J. Sekelsky, K.S. McKim, J.B. Boyd, and R.S. Hawley. 1995. The mei-41 gene of D. melanogaster is a structural and functional homolog of the human ataxia telangiectasia gene. Cell 82: 815-821.
15. Hartley, K.O., D. Gell, G.C. Smith, H. Zhang, N. Divecha, M.A. Connelly, A. Admon, S.P. Lees-Miller, C.W. Anderson, and S.P. Jackson. 1995. DNA-dependent protein kinase catalytic subunit: A relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 82: 849-856.
16. Hunter, T. 1995. When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell 83: 1-4.
17. Kastan, M.B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R.W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51: 6304-6311.
18. Kastan, M.B., Q. Zhan, W.S. El-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597.
19. Khanna, K.K. and M.F. Lavin. 1993. Ionizing radiation and UV induction of p53 protein by different pathways in ataxiatelangiectasia cells. Oncogene 8: 3307-3312.
20. Kuerbitz, SJ., B.S. Plunkett, W.V. Walsh, and M.B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. 89: 7491-7495.
21. Lehmann, A.R. 1982. Ataxia-Telangiectasia: A cellular and molecular link between cancer, neuropathology and immune deficiency (ed. B.A. Bridges and D.G. Harnden), pp. 83-102. Wiley, Chichester, UK.
22. Li, E., T.H. Bestor, and R. Jaenisch. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915-926.
23. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.
24. Lu, X. and D.P. Lane. 1993. Differential induction of transcriptionally active p53 following UV or ionizing radiation: Defects in chromosome instability syndromes? Cell 75: 765-778.
25. Macleod, K.F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DMA damage. Genes & Dev. 9: 935-944.
26. Meyn, M.S. 1995. Ataxia-Telangiectasia and cellular responses to DNA-damage. Cancer Res. 55: 5991-6001.
27. Morrow, D.M., D.A. Tagle, Y. Shiloh, F.S. Collins, and P. Hieter. 1995. TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1. Cell 82: 831-840.
28. Mortensen, R.M., D.A. Conner, S. Chao, A.A. Geisterfer-Lowrance, and J. G. Seidman. 1992. Production of homozygous mutant ES cells with a single targeting construct. Mol Cell. Biol. 12: 2391-2395.
29. Mosner, J., T. Mummenbrauer, C. Bauer, G. Sczakiel, F. Grosse, and W. Deppert. 1995. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J. 14: 4442-4449.
30. Sdi1 antisense RNA. Proc. Natl. Acad. Sci. 92: 4352-4356.
31. Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
32. Paulovich, A.G. and L.H. Hartwell. 1995. A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage. Cell 82: 841-847.
33. Robertson, E.J. 1987. Embryo-derived stem cell lines. In Teratocarcinomas and embryonic stem cells: A practical approach (ed. E.J. Robertson), pp. 71-112. IRL Press, Oxford, UK.
34. Savitsky, K., A. Bar-Shira, S. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D.A. Tagle, S. Smith, T. Uziel, S. Sfez, M. Ashkenazi, L. Pecker, M. Frydman, R. Harnik, R.P. Sankhavaram, A. Simmons, G.A. Clines, A. Sartiel, R.A. Gatti, L. Chessa, O. Sanal, M.F. Lavin, N.G.J. Jaspers, M.R. Taylor, C.F. Arlett, T. Miki, S.M. Weissman, M. Lovett, F. Collins, and Y. Shiloh. 1995. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753.
35. Shiloh, Y., E. Tabor, and Y. Becker. 1985. In vitro phenotype of ataxia-telangiectasia (AT) fibroblast strains: Clues to the nature of the "AT DNA lesion" and the molecular defect in AT. Kroc Found. Ser. 19: 111-121.
36. Smith, C.A., G.T. Williams, R. Kingston, E.J. Jenkinson, and J.J. Owen. 1989. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337: 181-184.
37. Swift, M., P.J. Reitnauer, D. Morrell, and C.L. Chase. 1987. Breast and other cancers in families with ataxia-telangiectasia. N. Engl. J. Med. 316: 1289-1294.
38. Swift, M., D. Morrell, R.B. Massey, and C.L. Chase. 1991. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N. Engl. J. Med. 325: 1831-1836.
39. Thacker, J. 1994. Cellular radiosensitivity in ataxia-telangiectasia. Int. J. Radiat. Biol. 66: S87-96.
40. Weinert, T. and D. Lydall. 1993. Cell cycle checkpoints, genetic instability and cancer. Semin. Cancer Biol. 4: 129-140.
41. Xiong, Y., G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
42. Xu, Y., T. Ashley, E.E. Brainerd, R.T. Bronson, M.S. Meyn, and D. Baltimore. 1996a. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes & Dev. (this issue).
43. Xu, Y., L. Davidson, F.W. Alt., and D. Baltimore. 1996b. Deletion of the IgK light chain intronic enhancer/matrix attachment region impairs but does not abolish VKJK rearrangement. Immunity 4: 377-385.
44. Zakian, V.A. 1995. ATM-related genes: What do they tell us about functions of the human gene? Cell 82: 685-687.